NYSE:ENOVMedical Equipment
Enovis (ENOV) Is Down 5.5% After 2025 Loss And 2026 Revenue Outlook Update - Has The Bull Case Changed?
Enovis Corporation recently reported fourth-quarter and full-year 2025 results, including sales of US$575.76 million for the quarter and US$2.25 billion for the year, alongside a goodwill impairment charge of US$501.31 million that contributed to a full-year net loss of US$1.18 billion.
Alongside these results, Enovis issued 2026 revenue guidance of approximately US$2.31 billion to US$2.37 billion, signaling expectations for 4–6% organic growth even as substantial impairment charges continue...